Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ruxolitinib can cause a delayed skin reaction on the nose.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Targeting THY1 can improve skin repair and healing.

Oral JAK inhibitors effectively regrow hair in alopecia areata with a good safety profile.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

ATP helps prevent skin damage from vandetanib by reducing stress.

Icariside II may help treat gastric cancer by stopping tumor growth.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.